Displaying 10 out of 27 results

  1. New Content Item

    Agenus shares soar after cancer therapy deal with Gilead

  2. New Content Item

    Novartis strikes deal with Chinese firm to make Kymriah

  3. New Content Item

    Vital Therapies shares dive as liver system fails trial

  4. New Content Item

    Sienna Biopharma sinks after acne drug fails two trials

  5. New Content Item

    RedHill BioPharma has positive results from Crohn's disease trial

  6. New Content Item

    FDA declines to approve Insys Therapeutic's opioid painkiller

  7. FILE PHOTO: The GSK logo is seen on top of GSK Asia House in Singapore

    GSK's two-drug HIV treatment proves itself in key tests

    GlaxoSmithKline's simple two-drug treatment for HIV works as well as standard triple therapy, even in people with relatively high levels of the ...
  8. New Content Item

    Pfizer-Lilly pain drug found effective in late-stage study

  9. Britain's "three-parent baby" fertility treatments

    Tracking C-section pain patterns may benefit surgical patients